Acupuncture and Chinese herbs in the integrative management of post-COVID syndrome
- 24.11.2022
- COVID-19
- Schwerpunkt
Erschienen in:
- Verfasst von
- F. Lozano, M.D, PhD
- F. Alcala, M.D
- Erschienen in
- Deutsche Zeitschrift für Akupunktur | Ausgabe 4/2022
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA-type virus causing an acute respiratory infection (ARI) with different levels of severity ranging from a mild condition, like a common cold, to severe pneumonia and death. A clinical condition presenting 4–12 weeks after coronavirus disease 19 (COVID-19) infection, with persistent symptoms such as fatigue, cough, dyspnea, headache, myalgia, brain fog, and diarrhea, has been frequently recognized and is known today as post-COVID syndrome or long-COVID-19. Without a clear pathophysiology, research studies have proposed some secondary theories of SARS-CoV‑2 infection. This entity has also been studied from the perspective of traditional Chinese medicine, recognizing syndromes or patterns in the different stages or phases of the disease and emphasizing a more individualized treatment according to the predominant pathological condition. It is concluded that the integrative and complementary use of acupuncture and Chinese herbal medicine is highly effective and could be a main resource for the treatment of this syndrome.
Anzeige
- Titel
- Acupuncture and Chinese herbs in the integrative management of post-COVID syndrome
- Verfasst von
-
F. Lozano, M.D, PhD
F. Alcala, M.D
- Publikationsdatum
- 24.11.2022
- Verlag
- Springer Medizin
- Schlagwort
- COVID-19
- Erschienen in
-
Deutsche Zeitschrift für Akupunktur / Ausgabe 4/2022
Print ISSN: 0415-6412
Elektronische ISSN: 1439-4359 - DOI
- https://doi.org/10.1007/s42212-022-00520-x
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
